DAE HO LEE

Professor

Wonkwang University School of Medicine

South Korea

Research Interests

Explore related searches

Professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

DAE HO LEE is a Professor at Wonkwang University College of Medicine in South Korea. His research interests encompass metabolic diseases, particularly focusing on insulin resistance, non-alcoholic fatty liver disease, and related biomarker development. Recent publications include studies on DNA methylation during hyperinsulinemic clamp, metabolic implications of hepatic insulin resistance, and innovative diagnostic approaches for steatohepatitis and diabetic kidney disease.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

DAE HO LEE

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Acute Hyperinsulinemia during Hyperinsulinemic- Euglycemic Clamp Influences DNA Methylation and Gene Expression in Peripheral Blood Cells of Adult Men

Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications

Dynamic Lipidomic Remodeling and Clinical Correlations after Sleeve Gastrectomy in Obese Subjects

Comparison of Non-invasive Methods for Diagnosis of Non-alcoholic Fatty Liver Disease Before Bariatric Surgery and Postoperative Follow-up in Obese Patients

A Composite Blood Biomarker Including AKR1B10 and Cytokeratin 18 for Progressive Types of Nonalcoholic Fatty Liver Disease

Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus

Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation

Response to Letter to the Editor From Han and Xu: “Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes”

Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes

Plasma Metabolomics and Machine Learning-Driven Novel Diagnostic Signature for Non-Alcoholic Steatohepatitis

Development of a Predictive Model for Glycated Hemoglobin Values and Analysis of the Factors Affecting It

Overweight and Obesity are Risk Factors for Coronavirus Disease 2019: A Propensity Score-Matched Case-Control Study

Estimating Baseline Incidence of Conditions Potentially Associated with Vaccine Adverse Events: a Call for Surveillance System Using the Korean National Health Insurance Claims Data

Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease

Chronic kidney disease attenuates the impact of obesity on quality of life

Collaborators (8)

Byung-Chul Oh

Jeong Hee Hong

Ok-Hee Kim

Soon Hyo Kwon

Seong Min Kim

Yunju Jo

In‐Sun Hong

Seungyoon Nam

Make your next move.